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Bylaws are an important, vibrant 
document that both bind and build us as a 
medical staff. They are written by us, the 
practicing physicians of the medical staff, 
usually with input from Troika and the 
Department Chairs, but only after many 
revisions and debate from Division 
Chiefs, and the body of physicians they 
represent. They are, in the end, imperfect 
documents like the people who create 
them. The final language of any Bylaws 
change is reviewed by a practicing 
physician dominant Bylaws Committee, 
legal counsel for physicians, and then 
sent to the Medical Executive Committee 
before coming to the main body of the 
Medical Staff for final debate and vote. 
The recent proposed changes of the 
medical staff categories were the product 
oftwo years ofthinking and multiple 
iterations. Unanimously approved by the 
Medical Executive Committee, the 
Department of Medicine Executive 
Committee, Surgical Execufive 
Committee, and the Bylaws Committee, 
these changes were also approved by 
sweeping majority vote at the 
Departments ofMedicine, Surgery, 
Obstetrics and Gynecology, Pediatrics, 
Family Practice, and Psychiatry. Then, at 
the March quarterly meeting of the 
general medical staff, these changes were 
soundly defeated. 
Since that staff meeting, I have received 
dozens of letters and phone messages 
from physicians informing me that this 
vote reflected more the voice of Populist 
fervor than general disagreement with the 
principle issues before the assembly. 
Only time and deliberation will prove or 
deny this sentiment. As concluded at the 
meeting, I will encourage the Chairs to 
bring further debate to their members, to 
meet with the Chiefs of their Divisions 
and Sections and further deliberate the 
consensus of their department, for the 
issues on the table remain unsolved but 
solvable. In the end, these are OUR 
bylaws. They need to be thoroughly 
understood and approved by the working 
majority here and any changes should be 
embraced as necessary for the vibrant 
good of the physician staff as a whole. 
For the sake of clarity, let me charge 
these meetings with the challenges at 
hand: 
I. As we bring voice, vote, and economic 
accountability to Division and 
Department meetings, it will be 
increasingly important to define ourselves 
as Active staff. Decide what minimum 
level of activity should be required for an 
Active staff physician to retain the 
privilege of voice and vote at department 
meetings and to assure that already 
credentialed members remain in good 
standing in practice of patient care. 
2. For Courtesy staff, decide if there 
remains a need for this category for every 
Division and Department of the hospital 
medical staff, and where it is needed, 
whether activity in this class should be 
delineated. Currently, this category limits 
maximum number of patient contacts*, 
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not subject to the appeals process, but 
does not address minimum number of 
contacts to assure quality standards. For 
surgery, for example, the department 
recommended a minimum number of six 
operations per year, not subject to appeal, 
to remain vibrant in this category. Keep 
in min.d that QA and credentialing remain 
the very reason we gather together as an 
organized medical staff and that this · 
process should be driven and directed by 
physicians, not managed care companies 
for business administrators. We have all 
heard the argument that numbers of 
contacts alone do not equate to quality 
and with this I think we can agree. On 
the other hand, with no numbers, quality 
cannot be judged, much less assured to 
our patient population. Where there are 
quality concerns in any category the fair 
hearing process is currently guaranteed. 
3. Decide a class and category for our 
relationship with PennCARE affiliates. 
Decide what privileges, rights and powers 
physicians should have in this category 
which fosters collaboration without 
unfairly tipping the delicate balance of 
resources and interactions with our 
current staff. 
4. Re-examine our current use of the fair 
hearings policy as delineated in the 
Medical StaffBylaws and determine if it 
is indeed a fair process (see attached). 
. We have made no recommendations to 
change it to date. Originally designed 
and currently in use over 20 years, this 
appeals process was created to protect the 
rights of physicians who were called to 
lose privileges because of quality 
concerns. It is not currently called into 
play for physicians who wish to exceed or 
fall short of current activity levels 
recommended for a category as these 
activity levels were designed to be 
minimal standards. If, for example, you 
decided that Courtesy staff should have 
no more than 12 contacts (defined below) 
in Medicine, should physicians who wish 
to exceed this without becoming Active 
staff be recommended to the fair hearings 
process? Should physicians in the 
Courtesy category with essentially no 
activity here in medicine (i.e. Jess than 
one patient contact per year) be 
recommended to appeal or simply moved 
to the Referring level of activity? We 
have supported the fair hearing process 
for issues of quality not for issues of 
simple category designation. 
We welcome your suggestions through 
the Chief and Chair meetings, through 
personal communication or by voice mail 
on the 402-DOCS hotline. 
Lastly, let us open debate on the issue of 
the Staff Development Plan in general. 
We will do this at the April meeting of 
the Medical Staff/ Administrative 
Exchange session and hold future debate 
and discussion if there is a will to do so. 
This plan was designed to allow 
measured growth of our medical staff in 
an equitable way which meets the 
community needs and does not tip the 
delicate balance of hospital resources. 
Without it, unlimited and unrestrained 
growth in every specialty and 
subspecialtY would be permitted, 
controlled only by the limits placed on 
practices through internal competition. 
Let's open debate on the two alternatives, 
and deliberate on which is best for the 
community of patients and physicians this 
hospital serves. 
John E. Castaldo, MD 
President, Medical Staff 
*The tenn "patient contact" means the 
provision by a Medical Staff member of a 
History and Physical Examination, or 
provision of a consultation, or an admission of 





1995 Physician Survey Helps LVHHN Identify 
Successes, Problems 
Despite a myriad of issues and changes 
currently challenging health care 
providers, Lehigh Valley Hospital and 
Health Network's Medical Staff is 
"generally pretty pleased with the 
services of Lehigh Valley Hospital and 
Health Network," says John E. Castaldo,' 
MD, Medical Staff President. He bases 
his observation on the results ofthe 1995 · 
physician survey, which he calls a "good 
barometer" to identify successes and 
problem areas at LVHHN. The 157 
physicians who completed the survey 
gave L Vfrn.N an overall score of 4, with 
a rating ofS equating to "excellent." 
Twenty-one percent of the 750 Medical 
Staff members completed the four-page, 
I 08-item questionnaire in December. In 
1994, the first year it was conducted, 140 
doctors filled out the survey, which had 
an overall average of3.919. Both ofthe 
surveys were sponsored by Medical Staff 
Services. 
The respondents rated clinical and 
administration in 33 programs and 
services and· in anesthesia, emergency, 
imaging, and pathology services. 
Nursing care and management on patient 
care units were also measured; and 
outpatient, support, and edu~ation 
programs \vere rated for general 
satisfaction. 
"This is an opportunity for our Medical 
Staff to contribute to change, to learn 
trom the successes, and to improve areas 
not doing well," Dr. Castaldo said. "This 
information will be used to make the 
hospital a better place." 
"I hope that our Medical Staff 
understands that even in these turbulent 
times, L VffiiN is focused on making our 
services the first choice of physicians 
taking care of our community," said 
Louis Liebhaber, Chief Operating 
Officer. "The high level of physician 
satisfaction results from serious attention 
by the rest of the L VHHN team members 
to providing high-quality patient- and 
physician-friendly care." 
Following are the highlights of the survey 
results: 
The Cardiac Catheterization Lab repeated 
this year as the survey's number one 
"Clinical" area. For this honor, Bret 
Bissey, Administrative Director, 
Department of Medicine, credits the cath 
lab's "excellent physician leaders and 
dedicated staff who strive to provide 
outstanding customer satisfaction." 
According to Mr. Bissey, further 
improvements, initiated in March, include 
the redesign of processes to reduce 
patient waiting time and increase 
procedure room use. 
Gary Marshall, Oncology Administrator, 
said he is pleased by oncology services' 
leap forward from number 20 to seven. "I 
think this reflects the continuous 
improvement process by the Morgan 
Cancer Center management and staff in 
trying to understand and satisfy the needs 
of the patients and physicians we serve," 
Mr. Marshall said. 
Radiation Therapy ranked number two 
this year, and the GI/Endoscopy Lab 
placed third for the second time. In 
addition, Outpatient Pediatrics moved up 
I 0 places, from 22 to 12. 
The Open Heart Unit (OHU) rated first in 
the "Nursing Units" category, moving up 
from second place in 1994. Geary 
Yeisley, MD, OHU Medical Director, 
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links this achievement to "the nursing 
staffs first-rate technical skills and 
collaborative spirit, and the strong 
leadership of Kathleen Sullivan, Director, 
Patient Care Services, OHU/TOHU. 
The first unit to implement patient 
centered care -- 7 A -- showed the greatest 
improvement, placing 12th in 1995 
compared to 31st in 1994. Dr. Castaldo' 
believes this advance reflects doctors' 
acceptance and the benefits of patient 
centered care. 
Under the heading "Programs, Patient 
Administration, Physician Services," 
Biomedical Photography and Lehigh 
Valley Hospice ranked first and second, 
respectively, both repeating from 1994. 
Patient Education advanced from 21 in 
the first year to seven in 1995, and O.R. 
Scheduling moved up 10 slots to 21. 
Patient ed specialist, Deb McGeehin, 
believes that improved collaboration 
through patient centered care, and efforts 
to achieve consistent discharge 
instructions and better documentation of 
patient teaching have helped throughout 
the hospital. 
The O.R. Scheduling staffwas praised for 
its progress by Herbert "Chuck" Hoover, 
MD, Chairperson, Department of 
Surgery: "They have made remarkable 
improvements by streamlining the 
scheduling process and now work more 
closely with medical office staffs to better 
accommodate both patients and 
physicians." 
Lehigh Magnetic Imaging Center placed 
first, and anesthesia at the Fairgrounds 
Surgical Center placed second in the 
"Anesthesia, Emergency Services, 
Imaging, Pathology Services" division of 
the survey, duplicating their 1994 
rankings. 
Each department will receive its survey 
results. Dr. Castaldo believes that 
constructive feedback will lead to 
improvements throughout the network. 
"We need to praise the best departments 
and encourage them to continue their 
excellent work. The a.reas needing 
improvement will be supported in their 
efforts, and the lessons from the top 
performers will be shared to help improve 
the hospital," he said. 
HIV Antigen Testing of Donor Blood (P-24) 
Beginning the week of March 18, Miller 
Mem'orial Blood Center began testing 
donor blood with a newly approved test 
required for donor testing called the HIV 
P-24 Antigen Test. This testing 
supplements current testing and is 
positive earlier in infection reducing the 
"window phase" when a person is 
infected by HIV but not positive by 
laboratory methods from 24-26 days to 
approximately 16 days. The risk of HIV 
infection from blood transfusion has 
recently been reviewed and current 
estimates of risk are from 1 :440,000 to 
1 :640,000 or approximately 1 in 500,000 
transfused units. Locally, of 
approximately 83,000 donors screened in 
the last 18 months by the currently 
employed antibody test, only two were 
positive for antibody to HIV and those 
donations were discarded. Thus, the 
incidence ofHIV antibody in the local 
donor pool is very low and hence so is the 
risk ofHIV transmission. It is estimated 
that nationwide the new test will identify 
about seven cases of early HIV infection 
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among donors. The cost is about $50 
million annually. The cost per quality 
adjusted life years is estimated to be $2.3 
million. 
It is the intention of the Blood Center to 
comply with a January 6, 1996 American 
Association of Blood Banks Bulletin to 
begin testing. During the transition 
period during which the inventory of the' 
Blood Center is being tested, the AABB 
has recommended that each hospital and 
its Medical Staff establish a mechanism 
to address relevant transfusion practice 
issues. These Include minimizing the 
number of transfusions during the 
transition phase (as long as a week) and 
in the cast of surgeries requiring 
transfusion, discussion with potential 
recipients about the test and the safety of 
the blood supply. 
Talking points to aid the discussion with 
potential recipients during the consent 
process include: 
News from Infection Control 
C. Difficile Alert 
Since the discovery ofC difficile as the 
etiologic agent of antibiotic-associated 
pseudo membranous colitis in 1978, a 
great deal has been learned about the 
pathogenesis, clinical manifestations, 
diagnosis, and epidemiology of this 
ubiquitous nosocomial pathogen. Despite 
this understanding, prevention and 
control of C difficile infections has been 
difficult. 
C difficile-associated diarrhea and colitis 
continues to be a MAJOR problem in our 
hospital. 
C difficile is the most important 
identifiable cause ofNOSOCOMIAL 
• With current testing methods, the risk of 
HIV infection from transfusion is 
approximately I :500,000. 
• The addition of the P-24 antigen test is 
estimated to identify nationwide seven 
donations that would not be detected 
otherwise each year. 
• Locally, the risk ofHIV transmission 
from blood is low because the number of 
units positive for antibody is low and hence 
the prevalence of HIV in the donor 
population is low compared to other areas 
of the country. 
• Regardless of how small, there is always 
a risk with allogeneic transfusion and the 
safest product is autologous when this is an 
option. Autologous donations are available 
at the Cedar Crest campus and can be · 
arranged by called 402-0650. 
If you have any questions regarding this 
issue, please contact Bala Carver, MD, 
Medical Director, Transfusion Medicine 
& HLA Lab, 402-8142, or David 
Beckwith, PhD, Vice President, 
Operations, and Clinical Director, Health 
Network Laboratories; 402-8150. 
infectious diarrhea in this country. 
Although the most common clinical 
manifestation of C difficile infection is 
diarrhea, the disease spectrum ranges 
from asymptomatic colonization or fecal 
excretion to pseudo membranous colitis 
(PMC) to TOXIC MEGACOLON, which 
may present with signs of an acute 
abdomen but WITHOUT diarrhea. Toxic 
megacolon is an important syndrome to 
recognize as it is associated with a high 
mortality rate and frequently requires 
surgical intervention. 
Symptoms of C difficile may consist of 
only a few loose stools per day or 
multiple, large-volume, watery stools and 
(Continued on Page 6) 
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signs of dehydration. Stools may have 
mucus or evidence of occult blood. In 
addition, a distinct fecal odor is often 
recognized. Other symptoms may 
include abdominal pain, ileus, fever, and 
leukocytosis. 
As noted earlier, there has been an 
INCREASE in the number of C difficile 
cases within our institution. It is 
IMPERATIVE that we adhere to the 
following Infection Control practices to 
prevent transmission of nosocomial C 
difficile-associated disease. 
1. BARRIER PRECAUTIONS 
Glove use when handling body 
substances 
Hand washing between patients 
Isolation precautions and cohorting 
2. ENVIRONMENTAL CLEANING 
AND DISINFECTION 
Patient rooms and bathrooms 
Equipment and environmental surfaces 
Bedside commodes 
3. IDENTIFICATION AND 
MANAGEMENT OF ASYMPTOMATIC 
CARRIERS 
4. MEASURES TO REDUCE THE 
RISK OF SYMPTOMATIC DISEASE 
Antimicrobial use restriction 
No single infection control practice alone 
can effectively prevent or control 
nosocomial C difficile infections. 
However, a combination of the practices 
together can MAKE A DIFFERENCE. 
Likewise C difficile is NOT the problem 
of just ONE patient care area, rather it is a 
problem that must be addressed by ALL 
PATIENT CARE AREAS. 
All disciplines must work together to 
combat this problem! 
If you have any questions, please contact 
Terry Burger in Infection Control at l 
402-0680. 
VRE Precautions 
Are we indeed on the horizon of what 
certain alarmists are predicting as the 
"post-antimicrobial era?" In recent years, 
a growing number of organisms have 
exhibited resistance to not only the old 
guard antibiotics, but also to the latest 
pharmacological concoctions being 
released on the market. Vancomycin 
resistant enterococcus (VRE) has been 
declared one of the hottest emerging 
pathogens having significant implications 
as a nosocomial organism in the hospital 
setting. Most alarming is the fact that 
VRE exhibits multiple resistance to a host 
of available antimicrobial agents with 
only a few dim prospects remaining for 
treatment. 
The emergence of VRE along with a 
number of other resistant organisms has 
been attributed to the intensive use of 
antimicrobials and the failure to 
consistently apply basic infection control 
practices and procedures. A recent 
consensus statement made in JAMA, 
(January 17, 1996- Vol. 275, No.3, pgs. 
234-240) calls for a multidisciplinary, 
systems-oriented approach to address the 
current crisis we are experiencing due to 
the rising incidence and spread of 
resistant organisms. The statement was 
made by a group of experts from hospital . 
epidemiology and infection control, 
infectious diseases, clinical practice, 
pharmacy, administration, quality 
improvement, medical informatics, and 
outcomes. The group was challenged 
with the task to provide hospital leaders 
with "strategies to prevent and control the 
emergence and spread of antimicrobial-
resistant microorganisms in hospitals." 
.(Continued on Page 7) 
PageS 
(Continued from Page 6) 
The contributors to the consensus 
statement developed strategic goals to 
guide hospitals in the fight against the 
rising resistance of microorganisms. The 
goals were directed toward creating 
delivery systems to optimize 
antimicrobial use and establishing 
methods to detect, report and prevent the 
transmission of antimicrobial resistant 
organisms. One of the goals 
recommended that hospitals develop a 
plan for discharging, and readmitting 
patients colonized with specific 
antimicrobial resistant pathogens. 
The Centers for Disease Control also 
recognizes that aggressive infection 
control measures must be undertaken to 
reduce the nosocomial spread of VRE. 
Since patients with VRE may remain 
colonized with the organism for long 
periods following discharge, the CDC 
recommends a system be in place to 
highlight the records of these patients so 
they will promptly be placed in isolation 
if readmitted. In an attempt to comply 
with the recommendations from the CDC 
published in the MMWR, the Infection 
Control Department has found it 
necessary to develop a process which 
would flag patients in our computer 
system who have been identified with 
VRE. Upon readmission, the VRE 
patient will then be directly placed on the 
·appropriate isolation precautions. 
Effective March 1, the Infection Control 
Department began the process of 
highlighting patient records with VRE 
infections. Should the patient be 
readmitted in the future, their pre-admit 
screen will indicate that they must be 
admitted into a private room under 
isolation precautions. 
If you have any questions or comments 
regarding this new process, please contact 
Terry Burger in the Infection Control 
Department at 402-0680. 
News from the County Medical Society 
Over 2, 700 physicians, their families, and 
their staff signed up to come to 
Harrisburg to participate in the Tort 
Reform Rally originally scheduled for 
January 23, 1996. As you may be aware, 
the rally had to be postponed due to the 
state-wide flood emergency that occurred 
just prior to the 23rd. The rally has now 
been rescheduled for May 7, but we need 
your help to rekindle the enthusiasm that 
had been created during the planning 
process for the earlier one. 
For planning purposes, below is the 
preliminary schedule for the rally. All 
times are approximate. 
10 to 10:30 a.m.- Arrive in Harrisburg 
11 a.m. - Pre-rally/Box lunch 
Noon to 1 p.m. - Travel to Capitol 
1 to 2 p.m. - Rally 
2 to 3 p.m. - Visit Legislators 
3:30p.m.- Depart for Home 
Please make every effort to be present or 
have your practice represented at this 
very important event for the future of 
medicine in Pennsylvania! 
Contact Lou Eister at the Lehigh County 
Medical Society at 437-2288 to confirm a 
reservation and/or arrange bus 
transportation. 
Robert X. Murphy, Jr., MD 
Chairman, Legislative Committee 
Lehigh County Medical Society 
and 
HMSS Representative 
Lehigh Valley Hospital 
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Incentive Program Rewards Cost-Saving Ideas 
Want to win a free trip, a new TV or stereo, or 
maybe a new set of golf clubs? A new 
operations improvement (01) incentive 
program to be launched this spring at Lehigh 
Valley Hospital and Health Network 
(L VHHN) will award merchandise, vacations, 
and cash to employees, physicians, volunteers, 
and auxiliary members who provide valuable 
OI ideas. 
Beginning in May, individuals and teams can 
help L VHHN become a more cost-effective 
health provider and earn great prizes. And if 
L VHHN's FY '96 01 goal of $20 million is 
reached, all incentive program winners will 
receive bonus prizes. 
The 01 incentive program will provide the 
energy to "jump-start" the cost-savings 
efforts, according to Lou Liebhaber, COO. 
"To be a true success, the OI program must 
have the help of the more than 4,000 people 
who work or volunteer here each day," he 
said. As of the end of February, more than 
$8.4 million of this fiscal year's $20 million 
OI goal has been achieved. 
The program will be launched in May at 
meetings around the clock. Coaches and other 
resource personnel, recruited from middle 
management, will explain the rules and 
reward structures and distribute the materials 
needed to participate in the program. They 
will work with groups that want to propose 01 
projects. Each attendee who signs up for the 
program at the launch will receive a free gift 
bearing the L VHHN logo. 
The concept for the program was developed 
by Lou Liebhaber with the input of a group of 
employees and physicians who have been 
working on the details since January. 
"This program will be fun and rewarding, and 
help L VHHN improve its competitive position 
in the local health care marketplace," Mr. 
Liebhaber said. "Many employees have 
suggested an incentive program to help us 
involve more people. To succeed, we must 
rely on our colleagues to identify 01 
opportunities in their daily work." 
In addition to rewards for suggesting 01 
projects, the person or team providing the idea 
with the highest cost-savings value each 
quarter will receive a special prize. It could 
be a trip, cash, or another form of reward. 
Jim Burke, Vice President, will lead 
L VHHN's 01 incentive efforts. He will be 
assisted in the necessary development, launch, 
and operation of the program by the BI 
Employee Performance Group of 
Minneapolis. According to Mr. Burke, BI has 
a proven track record for helping 
organizations rally their members to reduce 
costs. "They have had tremendous success 
with hospitals and companies nationwide. In 
Philadelphia, they've helped Pennsylvania 
Hospital, Jefferson, and the Hospital of the 
University of Pennsylvania save millions of 
dollars." BI will be involved in setting the 
program rules, training coaches and other 
resource personnel from the network, and 
providing reference and "how-to" materials. 
Their compensation will be based on a 
percentage of the total 01 savings. 
If you have any questions or comments 
regarding this program, please contact Jim 
Burke at 402-9790. 
For Your Information 
X A new card access lock has been 
installed for the Medical Record Department 
at 17th & Chew for your convenience. 
During the hours when Medical Records is 
closed (Monday through Friday - midnight to 
7 a.m., and Saturday, Sunday, and holidays 
- 3:30 p.m. to 7 a.m. the following morning), 
you may use your 1.0. badge for access. 
X The Email department name has been 
changed from SA Med/Surg to Trans 
Trauma Unit. A new public mailing list has 
also been created to reflect the name 
change. The mailing list name is: 





L VHHN Continues to Respond to Trends 
Lehigh Valley Hospital and Health 
Network (L VHHN) continually evaluates 
the impact of daily inpatient census 
trends, program changes, and 
construction. Beds were recently closed 
on several patient care units at Cedar 
Crest & 1-78. 
The hospital is currently licensed for 842 
beds (including 52 skilled nursing beds), 
and 679 are staffed. The decreasing 
inpatient census at L VH and relocation of 
day-of-procedure-admission (DOPA) 
beds from 3C resulted in the closing of 10 
beds on 4A, reducing the registered 
nursing staffby 5.3 FTEs and nursing 
technical assistant FTEs by 1.4, according 
to Terry Capuano, Administrator, Patient 
Care Services. Displaced employees are 
receiving support from the network in 
their efforts to find new positions. 
Moving the DOPA beds to 4A made 
room for the redesign of the invasive 
cardiology area, formerly the Cardiac 
Cath Lab and 3C. 
A special four-bed room was built on 4A 
to enhance the continuity of care of 
Cardiac Cath Lab Redesign 
Implemention of the redesign of the 
Invasive Cardiology Area, formerly the 
Cardiac Catheterization Lab and 3C, 
occurred on March 4. The redesign is the 
result of a collaborative effort of 
administration, physicians, and clinical 
staff that began a little over a year ago 
and is rooted in the patient centered care 
philosophy. · 
The goal of the Invasive Cardiology Area 
is to provide the highest level of care and 
the best patient outcomes at the lowest 
unit cost. Major objectives of the 
redesign include: 
vascular surgery patients, who can now 
be discharged sooner, according to Jane 
Barbe, Patient Care Director, 4A and 4C. 
Fourteen beds were recently closed on SA 
(transitional trauma) to make room for a 
physical therapy gym and accommodate 
renovations for patient centered care, 
according to Marilyn Guidi, RN, Patient 
Care Director, SA and Shock/Trauma 
Unit. Five employees have been 
displaced through this process. 
"Because of the impact of managed care 
on admissions, we must adjust our 
number of inpatient beds to match the 
hospital's needs, Mrs. Guidi said. 
According to Mary Kinneman, Senior 
Vice President, Patient Care Services, the 
current approach to trimming operations 
in response to the falling census provides 
two opportunities for improvements. 
"Closing only part of a unit allows us to 
save on personnel costs and convert 
clinical space into support and storage 
areas." 
• Decreased patient waiting time 
• Increased room utilization 
• Minimization of overtime expenses 
• Establishment of a cost-competitive 
market 
• Increased capacity for future patient 
volume 
From an operational perspective, 
implementation of the redesign will 
bring: · 
• A dedicated electrophysiology program 
(Continued on Page 1 0) 
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• New scheduling guidelines and 
improved tum around efficiencies in the 
Cardiac Cath Lab area 
• Integrated documentation systems 
• Revised CareMaps for each patient 
type 
• Changes in skill mix and cross training 
in all areas 
• The dedication of the former 3C area to 
the care of Cardiac Cath Lab patients. 
All outpatients and inpatients having a 
Cardiac Cath Lab procedure will remain 
on 3C for their post procedure care up to 
a 24 hour periqd. After 24 hours, an 
evaluation of the patient's needs will 
occur to determine appropriate patient 
placement. The 3C area will be 
operational Mondays at 6 a.m. through 
Saturdays at 3:30p.m. 
• Plac·ement of inpatients formerly on 3C 
on other patient care areas; movement of 
inpatients formerly on other critical care 
units post Cardiac Cath Lab procedure to 
3C 
• Movement of DOPA to 4A 
If you have any questions or comments 
regarding the redesign of the Invasive 
Cardiology Area, please contact Robert 
Oriel, MD, Medical Director, Cardiac 
Catheterization Lab; or Julie Clelland or 
Bob Baumgartner, Co-Directors, Invasive 
Cardiology, at 402-8660. 
News from the Center for Educational Development & Support 
Category 2 CME 
All physicians in Pennsylvania must 
participate in Continuing Medical 
Education (CME) activities sufficient to 
(a) fulfill the requirements of the AMA 
Physician's Recognition Award (PRA), or 
(b) fulfill the requirements of the 
Pennsylvania Medical Society. These 
requirements are slightly different, but 
each require participation in a minimum 
of 50 hours of CME each year, of which 
up to 30 hours may be designated 
Category 2. • 
Category 2 CME activities include 
clinical consultations contributing to the 
physicians education, QA/QC activities, 
teaching, journal clubs, self assessment 
examinations and reviews, computer 
based learning activities, journal or book 
publications, or attending programs 
designated as acceptable for Category 2 
education. Reading medical journals is 
not an acceptable activity for Category 2 
designation; it is assumed that all 
physicians read the medical literature 
regularly. 
Only organizations accredited to give 
Category 1 credit (Lehigh Valley Area 
Health Education Center) can authorize 
programs to advertise which programs 
fulfill the requirements for Category 2 
credit. 
Physicians are responsible for cataloging 
their own Category 2 activities. 
Questions or concerns can be directed to 
Jennie Hower in the Center for Education 
at 402-5243. 
PiliZIIIIII!!!II.- When you need 
to talk ... 
help is just a 
phone call away. 
Physician Assistance 
Program 
To arrange a confidential 
appointment or for more 
· information, call 
(61 0) 433-8550 or 
1-800-327-8878. 
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Penn CARE Partnership Marks Key Developments 
Two important developments for 
PennCARE signal increased momentum 
for the health partnership of physicians 
and eight hospitals that first organized in 
May 1995. 
First, the network has officially been 
incorporated in the Commonwealth of 
Pennsylvania, a move that now allows 
PennCARE to enter into contractual 
arrangements with insurance companies 
on behalf of participating hospitals and 
physicians. Second, PennCARE signed 
the first ofthose contractual 
arrangements, a long-term agreement 
with U.S. Healthcare, the region's largest 
health maintenance organization (HMO). 
Negotiations with other major insurers 
are also under way. 
"This is compelling evidence of our 
collective intent to create a market 
presence that is both powerful and 
lasting," said Elliot J. Sussman, MD, 
L VHHN President and CEO, and 
Chairman of the Board and President for 
PennCARE. "But more important, it is an 
acknowledgment to the people we serve 
that accessibility to high-quality, cost-
effective care is key to our communities' 
well-being." 
PennCARE's incorporation, coupled with 
the U.S. Healthcare contract, creates in 
effect the region's first health network to 
blend the financing and delivery of health 
care, by bringing physicians, hospitals, 
and insurance companies together in a 
single entity, according to Thomas H. 
Hansen, Senior Vice President, Lehigh 
Valley Health Services Division. Mr. 
Hansen has been principally involved in 
the U.S. Healthcare negotiations and was 
recently elected secretary of the Board of 
Directors for PennCARE. 
"This kind of network integration creates 
tremendous incentives for physician and 
hospital partners in PennCARE to 
improve health care delivery, lower costs, 
and generally enhance the health of 
groups that enroll, said Mr. Hansen. 
"Everyone benefits in that kind of system. 
And employers who opt to offer network 
plans choose the best mechanism 
available to control their health care 
costs." 
Additional L VIDIN representatives on 
the Penn CARE Board of Directors 
include Joseph A. Candia, MD, and John 
Jaffe, MD. Both are also on the executive 
committee. 
Other PennCARE hospital members 
include: Doylestown Hospital, Gnaden 
Huetten Memorial Hospital in Lehighton. 
Grand View Hospital in Sellersville, 
Hazleton General Hospital, Hazleton-St. 
Joseph Medical Center, Muhlenberg 
Hospital Center in Bethlehem, and North 
Penn Hospital in Lansdale. Penn State 
University's Hershey Medical Center will 
participate through a contract for highly 
specialized medical services. 
The medical staffs of the hospitals 
represent 2,230 physicians. The eight 
hospitals have a total of 1,877 beds, with 
more than 68,000 inpatient admissions 




17th & Chew Library Relocates 
Visit the Library in its newly renovated 
headquarters on the ground floor across the 
hall from the Medical Record Department. 
This Library, in its new location, will continue 
to provide essential resources to support the 
services at 17th & Chew. In addition, a new 
service-- a World Wide Web connection with 
full graphics capabilities -- has been added. 
As a convenience to beginner "web crawlers," 
a select number of home pages will be easily 
accessible through menu options. The Library 
also has a directory of listings for many other 
medical-related web sites. 
The new Library has a separate reading room 
which houses the current journal issues, the 
reference collection, and a computer for 
searching OVID. 
Some minor modifications have been made to 
the book and journal collections. The general 
history of medicine collection (excluding the 
Classics in Obstetrics, Gynecology, and 
Psychiatry) and the medical ethics collection 
have been transferred to the Cedar Crest & 
1-78 Library. The hospital's Historical 
Archives and the School of Nursing Alumni 
have provided homes for many of the old 
textbooks. 
A few backfiles of journals have been 
transferred to the Cedar Crest & 1-78 Library, 
and some are being temporarily stored. There 
will be no change in the journal titles offered. 
As always, inter-library loan services will be 
provided for materials not owned by either of 
the hospital's libraries. 
Chad Carver has been very instrumental in the 
design of this new facility. Most of the 
furnishings from the old location have been 
reused to minimize the cost of the 
renovations. Please stop by to say "hi" and 
"thanks" for a job well done. 
New Acquisition 
The following textbook was recently acquired 
at both library locations: 
Noble, Young, et al. Textbook of Primary 
Care. 2nd ed. Mosby, ·1996. 
TV Show to Feature Morgan Cancer Center 
WLVT-TV-39 will spotlight the John and 
Dorothy Morgan Cancer Center in a program 
on home care for cancer patients on April23, 
at 3 and 7:30 p.m. The show will feature the 
Family Caregiver Cancer Education Program 
(FCCEP), sponsored by the Pennsylvania 
Department of Health's Cancer Control 
Program. Because of the increased need for 
quality home care for cancer patients, the 
Department of Health implemented the 
FCCEP at four medical institutions, including 
LVH. 
Representatives from the Cancer Center 
appearing on the show will include Lorraine 
Gyauch, Director of the Family Caregiver 
Cancer Education Program; Louisa Weber, 
the bilingual oncology social work educator; 
and Therese Gyauch, Program Coordinator 
for Latino Outreach for FCCEP. 
As the time allotted for inpatient cancer care 
decreases, outpatient care must grow stronger. 
Often, however, caregivers must assume roles 
for which they are unprepared, both 
physically and emotionally. This places an 
additional strain on families and loved ones. 
The FCCEP offers education and support for 
patients and caregivers, thereby increasing the 
quality of life for all those involved. 
Resources available include the publication 
"Helping People Cope: A Guide for Families 
Facing Cancer," free through the Department 
ofHealth's toll-free phone number 1-800-PA-
CANCER, and the Latino outreach effort, 
which shares the FCCEP services with the 
Latino community through a Family 





Stepping Out ... 
MSWalk 
Did you know that about 300,000 
Americans suffer from multiple sclerosis 
(MS) and that it is the most common 
central nervous system disease of young 
adults in the United States? These are 
startling facts. 
Fortunately, the MS Society is dedicated 
to advancing the cure, prevention and 
treatment of MS and to improving the 
lives of those affected by this devastating 
disease. You and your family can help in 
these efforts by participating in the 1996 
MS Walk. 
The MS Walk is an exciting annual event. 
The benefits to participating are 
enormous. First, and most importantly, 
your pledges go to work right here in the 
Lehigh Valley helping those who suffer 
from MS. Team-building events, like the 
MS Walk, generate positive enthusiasm 
among employees. They build morale 
and increase the sense of teamwork 
within the organization. And the MS 
Society recognizes teams for their efforts 
by giving prizes and awards to the top 
· achievers. 
In 1995, Lehigh Valley Hospital won the 
award for "Best Rookie Team." Last 
year, more than 1,200 people on 50 
different teams from throughout the 
Lehigh Valley walked to raise more than 
$60,000 for medical research and support 
groups. 
This.year's 6-mile MS Walk will be held 
on Sunday, April 14, beginning at 8:30 
a.m., at the Muhlenberg Field House. 
Sign up now and join Alex Rae-Grant, 
MD, Lehigh Valley Hospital's Team 
Captain, in this very worthwhile event. 
For more information, contact Nancy 
Eckert in Neurosciences Research at 
402-9830 or through e-mail. 
WalkAmerica 
WalkAmerica, the annual fundraiser of 
the March of Dimes, is the nation's 
biggest walking event with over 1,400 
communities taking part nationally -- and 
it's coming to Allentown on Sunday, 
April28. The March ofDimes supports 
programs of research, community 
services, advocacy and public and 
professional health education to give 
more babies a healthy start in life. 
Believe it or not, the infant mortality rate 
in the United States is worse than 23 
other nations. Every two minutes, a low 
birthweight baby is born. Every hour, a 
baby dies due to a birth defect. In fact, 
one in five babies will die from a birth 
defect. Thanks to the efforts of the 
March ofDimes, thousands of families 
will be spared this tragedy. 
Our community and local hospitals 
benefit from WalkAmerica. Over the 
past 15 years, Lehigh Valley Hospital has 
received more than $325,000 in grants 
from the March of Dimes. In tum, we 
educate our patients and the community 
on maternal and child health and care for 
premature and sick infants using the latest 
technology. 
Lehigh Valley Hospital is organizing a 
team for WalkAmerica headed by James 
Balducci, MD, Chief of the Division of 
Obstetrics and Section of Maternal-Fetal 
Medicine. Teammates will receive aT-
shirt featuring the hospital logo and be 
eligible to win a variety of fabulous 
prizes. For more information or to 
register, contact Fran Derhammer at 402-
2903, or Gail Pitsko at 402-3001 or 
through e-mail. 
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Robin Roberts to Kick-Off Spirit of Women in Sports 
Robin Roberts, sports commentator for 
ESPN and ABC Sports, will be the 
keynote speaker for the kick-off of Spirit 
of Women in Sports, a first-time fitness 
event on April 19 and 20. The event is 
designed to encourage women of all ages 
to learn the physical and emotional 
benefits of involvement in sports. 
Organized by Cedar Crest College and 
Lehigh Valley Hospital in collaboration 
with the Women's Sports Foundation-- a 
national organization dedicated to 
fighting inequalities in women's sports 
funding -- and corporate and community 
partners including The Bon-Ton, Spirit of 
Women in Sports will be held on the 
Cedar Crest College campus. The two-
day event will begin with the first annual 
G.O.A.L.S. (Girls and Women's 
Opportunities for Achievement in Lehigh 
Valley Sports) awards ceremony 
honoring special achievements of the 
valley's female athletes and coaches on 
April 19 at 7 p.m. in Alumnae Hall 
Auditorium. Saturday's activities, from 
7:30a.m. to 12:15 p.m., will include a 
health and fitness expo in the Thompkins 
Center, and sports clinics in Lees Hall 
and on campus athletic fields: 
Ms. Roberts will open the G.O.A.L.S. 
ceremony with an inspirational talk about 
her experiences as a sports figure. This 
event marks the first time that the 
Women's Sports Foundation has 
sponsored its national awards in the 
Lehigh Valley. Grants supporting 
women's involvement in sports will also 
be awarded. 
Saturday's health and fitness expo and 
sports clinics are for females ages 8 and 
up. The expo will provide information 
from local experts on sports psychology, 
nutrition, strength and flexibility training, 
and Tai Chi. Health screenings will also 
be available. Sports clinics conducted by 
Lehigh Valley health and fitness 
professionals will feature interactive 
sessions on walking, running, weight 
training, softball, volleyball, tennis, 
basketball, and field hockey. 
According to Patrice Weiss, MD, 
Department of Obstetrics and 
Gynecology, Spirit of Women in Sports 
grew out of an idea of using role models 
and developing a network among girls 
and women that would promote their 
participation in sports. "We are creating 
a forum where girls and women can be 
introduced to sports and fitness activities 
by other women who have developed 
expertise in these areas. That's what 
makes Robin Roberts the ideal role model 
for this event. She is not only an 
established athlete, but also a hard-
working professional who integrated her 
enthusiasm for sports into her career and 
paved the way for women in the field of 
broadcast journalism," said Dr. Weiss. 
Spirit of Women in Sports is part of the 
ongoing initiatives of the Spirit of 
Women partnership that began in 1993 as 
a means of providing area women with a 
forum for exchanging ideas about health, 
work and family issues. Event organizers 
decided to broaden these initial themes by 
developing a program geared toward 
women's fitness and wellness-factors that 
can begin to shape one's quality of life 
from an early age. 
Registration for Spirit of Women in 
Sports is now underway. The G.O.A.L.S. 
awards ceremony with keynote speaker 
Robin Roberts is free of charge. The cost 
of the health and fitness expo and sports 
clinics is $20 for adults and $1 0 for girls 
under 18. A limited number of 
scholarships are also available for the 
event. For more information or to 






Andrew J. Pestcoe, DO, Division of 
Otolaryngology, received notification 
from the Bureau of Osteopathic 
Specialists of the American Osteopathic 
Association that they approved the 
recommendation of the American 
Osteopathic Board of Ophthalmology and 
Otorhinolaryngology to certify him in .· 
Otorhinolaryngology and Facial Plastic 
Surgery. 
Madhumati Raju, MD, Division of 
General Internal Medicine, was notified 
by the American Board of Internal 
Medicine that she passed the certifying 
examination and has now become 
certified as a Diplomate in Internal 
Medicine. 
Papers, Publications and Presentations 
Indru T. Khubchandani, MD, Division 
of Colon and Rectal Surgery, was the 
invited guest at the First Cuban Society of 
Coloproctology in Havana, Cuba, from 
February 12-14. The meeting was 
inaugurated by the Minister of Health and 
the Mayor of the City. Dr. Khubchandani 
lectured on "Incontinence" and "Setting 
Up Practice of Coloproctology." He was 
awarded Honorary Fellowship to "La 
Sociedad Cubana de Coloproctogia." 
Robert Kricun, MD, Vice Chairperson, 
Department of Radiology/Diagnostic 
Medical Imaging, and Michael D. 
Pasquale, MD, Chief, Division of 
Surgical Critical Care, presented lectures 
at the nursing Trauma Evening Seminar 
on March 11. Dr. Kricun presented 
"Radiology ofthe Chest in Trauma," and 
Dr. Pasquale presented ''Nutrition in 
Critical Illness." 
Carol B. Laurenzano, PsyD, 
psychologist, and David Mitchell, BSN, 
RN, ofthe Department of Psychiatry, in 
conjunction with Cecelia Grindel, PhD, 
RN, formerly ofNursing Research, co-
authored an article, "Sexual Abuse 
Assessment on Admission by Nursing 
Staff in General Hospital Psychiatric 
Settings," which was published in the 
February 1996 issue of Psychiatric 
Services. The authors surveyed inpatient 
psychiatric facilities nationwide and 
found that although nurse managers 
recognize the importance of including an 
assessment of patients' history of sexual 
abuse, there were several obstacles to 
implementing this procedure. 
Dominic P. Lu, DDS, Program Director, 
General Practice Residency Program in 
Dentistry, James F. Reed Ill, PhD, 
Director, Department of Research, and 
Gabriel P. Lu, MD, PhD, Assistant 
Professor, General Anesthesiology, 
Albert Einstein College of Medicine, co-
authored a paper, "Safety, Efficacy, and 
Acceptance of Intramuscular Sedation: 
Assessment of 900 Dental Cases," which 
was published in the November 1994 
issue of Compendium. This paper was 
the result of a joint research project 
between Lehigh Valley Hospital's Dental 
Department, Catholic Medical Center of 
Brooklyn and Queens Department of 
Dentistry - Canal University Medical 
College, and the Albert Einstein College 
of Medicine in New York. 
(Continued on Page 16) 
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Dr. Lu also authored "The Use of 
Hypnosis for Smooth Sedation Induction 
and Reduction ofPostoperative Violent 
Emergencies from Anesthesia in Pediatric 
Dental Patients," which was published in 
the May-June 1994 issue ofthe Journal 
of Dentistry for Children. 
In addition, Dr. Lu and Elliot V. Hersh, 
DMD, MS, PhD, Director, Pharmacology 
& Clinical Therapeutics, University of 
Pennsylvania, co-authored "Intra-Canal 
Dissolution of Sargenti Paste," which was 
published in the June/July 1994 issue of 
The New York State Dental Journal. 
This paper was the result of a joint 
research project between Lehigh Valley 
Hospital's Dental Department and the 
University of Pennsylvania School of 
Dental Medicine. 
James C. Weis, MD, Division of 
Orthopedic Surgery, presented a paper 
titled, "In Vitro Biomechanical 
Comparison of Multistand Cables to 
Conventional Cervical Stabilization 
Techniques," at the Cervical Spine 
Research Society meeting in Santa Fe, 
NM, in December. 
In addition, Dr. Weis presented a 
scientific exhibit titled, "Video Assisted 
Thoracic Surgery- Diskectomy," at the 
recent American Academy of 
Orthopaedic Surgeons meeting in Atlanta, 
Ga. 
Two abstracts co-authored by Steven L. 
Zelenkofske, DO, Division of 
Cardiology, were accepted for 
presentation at Cardiostim 96 which will 
be held in Nice, France from June 19-22. 
"A Prospective, Multi-Center Study 
Demonstrating Clinical Benefit with a 
New Accelerometer-Based DDDR 
Pacemaker" was selected for an oral 
presentation. "Heart Rate Variability in 
Chronotropically Incompetent Patients 
During a Prospective, Multi-Center 
Study," was selected for a poster 
presentation. Dr. Arnaud Lazarus, one of 
the co-authors, wiii be the presenter for 
both abstracts since he practices in 
France. 
Upcoming Seminars, Conferences and Meetings 
April Forums Scheduled 
In order to better facilitiate face-to-face 
dialogue between senior management and 
LVHHN employees and members ofthe 
medical staff, a number of forums have 
been scheduled for the end of the month. 
The forums wiii provide an opportunity 
for Lou Liebhaber, COO, to discuss the 
recently announced $13 miilion work 
force expense reduction effort with staff 
and physicians. He will also field 
questions and comments from those in 
attendance. 
Employees and medical staff members 
are encouraged to attend one of the 
following meetings: 
Tuesday, April23 -Noon to 1 p.m., 17th 
& Chew Auditorium 
Thursday, April 25 - 2 to 3 p.m., I 7th & 
Chew Auditorium 
Friday, April 26 - 3 to 4 p.m., 2024 
Lehigh Street 
Monday, April 29 - 7 to 8 a.m., and 2 to 3 
p.m., Cedar Crest & 1-78 Auditorium 
(Continued on Page 17) 
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Medical Staff/ Administrative 
Exchange Session 
The next Medical Staff/ Administrative 
Exchange Session will be held on 
Thursday, Aprill8, beginning at 5:30 
p.m., in Conference Room 1 - Side B of 
the John and Dorothy Morgan Cance~. 
Center. 
The topic for this session will include 
staff development/manpower issues. 
For more information, contact John E. 
Castaldo, MD, Medical Staff President, 
through Physician Relations at 402-9853. 
Regional Symposium Series 
Third Annual Current Trends in 
Cancer Care: Prostate Cancer will be 
held on Saturday, Aprill3, from 8 a.m. to 
I :20 p.m., in the Auditorium at Cedar 
Crest & 1-78. 
Medical and radiation oncologists, 
surgeons, urologists, internists, family 
practitioners, nurses, radiation 
technologists, and other health 
professionals interested in current trends 
in cancer care will benefit from this 
program. 
At the completion of this program, 
participants should be able to: 
• dispuss the role of combined modality 
staging for clinically localized prostate 
cancer 
• discuss the role of hormone therapy in 
the treatment of localized prostate cancer 
• identify the role of chemotherapy in the 
treatment of advanced prostate cancer 
• identify the current treatment outcomes 
for prostate cancer at Lehigh Valley 
Hospital 
• apply the theoretical discussion to 
actual case presentation 
Seventh Annual Pediatric Symposium: 
The Pediatric Athlete will be held on 
Thursday, April IS, from 12:40 to 5 p.m., 
in the Auditorium at Cedar Crest & 1-78. 
Pediatricians, family practitioners, 
psychiatrists, nurses, social workers, 
teachers, and other health and education 
professionals interested in pediatric 
athletes will benefit from this program. 
At the completion of the program, 
participants should be able to: 
• discuss the difference between the 
child and the adult athlete from an 
exercise perspective 
• demonstrate appropriate types of 
strength training for age of athlete 
• describe diagnose and recommend 
treatment for the various osteochondroses 
• perform a pre-participation fitness 
exam on the young athlete 
• recognize the abnormal spine in the 
youth who wishes to participate in sports 
• examine.and diagnose abnormalities of 
the knee, shoulder, elbow, ankle, and foot 
For more information on these programs, 
please contact the Center for Educational 
Development and Support at 402-121 0. 
Medical Grand Rounds 
The Use of Calcium Channel Blockers 
in the Treatment of Hypertension and 
Renal Disease will be presented by 
Howard Garfinkel, MD, Chief, Division 
ofNephrology, Danbury Hospital, on 
April9. 
(Continued on Page 18) 
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Newer Therapeutic Approaches in 
the Elderly will be presented by 
Harry Gavras, MD, Chief, 
Hypertension & Atherosclerosis, 
Boston University Medical Center, on 
April16. 
An Update on the Management of 
Lupus Nephritis - Emphasizing 
Long Term Side Effects will be 
presented by W. Joseph McCline, MD, 
Associate Chief of Clinical Activities, 
Division of Rheumatology, University 
of Michigan, on April 23. 
Osteoporosis - Guidelines for 
Therapy for the Practicing 
Physician will be presented by Melvin 
Horwith, MD, Division of 
Endocrinology, Penn State University-
Hershey Medical Center, on April 30. 
Medical Grand Rounds are held from 
noon to 1 p.m., in the Auditorium at 
Cedar Crest & 1-78. For more 
information, please contact the 
Department of Medicine at 402-8200. 
Department of Pediatrics 
HIV and AIDS Infection in 
Children & Adolescents will be 
presented by Richard M. Rutstein, 
MD, Children's Hospital of 
Philadelphia, on April 12. 
Update on the Treatment of 
Nephrotic Syndrome in ~hildren 
will be presented by Steven Wassner, 
MD, Chief, Division of Pediatric 
Nephrology, Hershey Medical Center, 
on April26. 
The above conferences will be held at 
noon in the hospital Auditorium at 
17th & Chew. For more information 
on the Pediatric conferences, please 






Dean A. Ruble, DO 
Whitehall Medical Center 
1250 Schadt Avenue 
Whitehall, PA 18052-3804 
(610) 434-4294 
FAX: (610) 439-1224 
Department of Medicine 
Division of General Internal Medicine 
Provisional Active 
Kathleen 0. Ververeli, MD 
Allentown Asthma and Allergy 
(Dr. Israel) 
1605 N. Cedar Crest Blvd. 
Suite 605 
Allentown, PA 18104-2304 
(610) 820-9000 
FAX: (610) 820-9078 
Department of Pediatrics 
Division of Allergy 
Provisional Active 
Address Change 
Peter H. Goldman, MD 
1251 S. Cedar Crest Blvd. 
Suite208D 
Allentown, PA 18103-6205 
New Practice Affiliations 
Matthew A. Kasprenski, MD 
Oakwood Medical Center 
951 N. Fourth Street 
Allentown, P A 18102-1899 
(610) 434-8801 
Stephan R. Sher, DO 
Lehigh Valley Family Health Center 
1730 Chew Street 
Allentown, PA 18104-5595 
(610) 402-3500 
FAX: (610) 402-3509 
Leadership Appointments -
Department of Surgery 
Steven J. Lawrence, MD 
Chief, Section of Foot and Ankle. Surgery 
Robert D. Riether, MD 
Director, Colon/Rectal Residency 
Program 







Guila Glosser, PhD 
Department ofNeurology- 3W Gates 
University ofPennsylyania Medical 
Center 
3400 Spruce Street 
Philadelphia, PA 19 I 04-4283 
(215) 662-3371 
Resignation 
Mary Ellen Lynch, CNM 
Physician Extender 
Professional - CNM 





P & T HIGHLIGHTS 
The following action were taken at the February 21, 1996 Pharmacy and Therapeutics Committee Meeting -Maria Barr, 
Pharm.D., BCPS, Barbara Leri, Pharm.D., Janine Barnaby, R.Ph., Man Mauro, R.Ph. 
CALCITONIN- THE 
"NOSE" HAVE IT! 
Calcitonin-salmon nasal solution 
(MiacalcinR) has been added to the 
formulary for treatment of post-
menopausal osteoporosis in women with 
low bone mass or who cannot take 
estrogens. It is similar to the calcitonin 
injection, which is currently on formulary. 
The most common side effects include 
rhinitis, back pain, arthralgia, epistaxis 
and headache. There is a potential allergic 
reaction because calcitonin salmon is a 
protein. There are some advantages over 
the traditional subcutaneous injection. 
They are improved patient acceptance, 
decreased incidence of GI upset and no 
adjustment in dosage in renal impairment. 
P~tients will have to be taught the proper 
technique when using the solution, if 
initiated in the hospital. 
The dosage is one spray to a single nostril 
per day which delivers 200 iu/day. It is 
recommended to alternate nostrils for the 
daily dose. Each nasal spray bottle 
contains a 2 week supply of drug. The 
dispensing procedure for nasal calcitonin is 
in the process of being outlined for 
patients being initiated and discharged on 
this therapy. 
Cost Comparison: 
Nasal calcitonin 200 iu/day = $20.80 (acquisition cost) 
Subcutaneous calcitonin 50 iu/day = $24.00 
"FAT-FREE" 
AMPHOTERICIN B 
REMAINS THE AMPHO B 
OF CHOICE AT L VH: 
Amphotericin B Lipid Complex injection 
(AbelcetR) is a new lipid-drug suspension 
of the antifungal amphotericin B. AbelcetR 
was presented to P&T in February but was 
not added to the formulary at this time. 
The review of the medication is presented 
for your information. AbelcetR is indicated 
for the treatment of aspergillosis in 
patients who are refractory to or intolerant 
of conventional amphotericin B therapy. 
AbelcetR is a complex of amphotericin B 
and two phospholipids in a 1:1 drug-lipid 
molar ratio. The lipid-stabilization of 
amphotericin B accounts for the potential 
for lower adverse effects and to increase 
the amount of amphotericin B that can be 
given in a single dose. 
The major side effects associated with 
AbelcetR are, as with regular amphotericin, 
transient chills and fever during infusion of 
the drug. Other side effects include: 
headache, abdominal pain, hypotension, 
nausea, vomiting, diarrhea, 
thrombocytopenia ( 4%), anemia ( 4%), 
leukopenia (4%), increased serum 
creatinine ( 11-12%), renal failure ( 5 %) , 
hypomagnesemia, hypokalemia, 
hypocalcemia. AbelcetR can increase some 
lab values such as AST, AL T, alkaline 
phosphatase, and BUN. 
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The recommended adult and child dose is 
5mg/kg/day given as a single infusion. 
The infusion should be run at a rate of 
2.5mg/kg/hr. The bag containing the 
suspension will need to be shaken if the 
infusion time is greater than two hours. 
The fmal concentration of the I. V. solution 
should be 1mg/ml. For patients with 
cardiovascular disease and pediatric 
patients a concentration of 2mg/ml may 
be, utilized if necessary. AbelcetR may 
only be mixed in 5% dextrose solution due 
to stability reasons. 
The advantages of amphotericin B in a 
lipid complex is that it appears to be 
associated with less nephrotoxicity. 
AbelcetR is also an alternative for the 
treatment of aspergillosis. A disadvantage 
is a 30 fold increase in cost compared to 
conventional amphotericin B. Also, there 
is limited clinical data available to date, 
regarding direct comparison of liposomal 
amphotericin B with conventional 
amphotericin B. 
Cost Comparison Usual Adult Dose Cost/day 70Kg Pt 
amphotericin B Smg/kg/day $472.50 
Lipid Complex 
(supplied as a single use only vial) 




EXCEPTION FOR 7A 
DIALYSIS 
Due to the dialysis schedules of patients 
and the potential removal of medications 
by dialysis, all QD medications are 
administered at 1800. As a result, 7A will 
be the exception to the new policy of 
dosing warfarin at 1200. 
THE SUBSTITUTION 














NO PROBLEMS WITH 
ZOLPIDEM (AMBIENR) 
CRITERIA 
Starting 10/5/95, the pharmacy 
department, under the guidance of the P & 
T Committee, initiated automatic 
substitution of zolpidem with oxazepam 
unless one of the following criteria were 
met: 
- Age > 65 years AND est. CrCI 
< 30ml/min 
-- Hypersensitivity to benzodiazepines 
- COPD with C02 retention (pC02 >50) 
- Continuation of home therapy 
The results of the evaluation for the last 3 
months reveals a decrease in the average 
number of zolpidem patient~ from 37 
patients/month to 16 patients/month. The 
primary reasons for use of zolpidem are 
continuation of home therapy (34%) and 
age and renal dysfunction (34%). 
Based on the continued use of this 
medication and its overall decline in use 
over the past 3 months within the 
institution, zolpidem will remain on 
formulary with the same guidelines for 
use. If additional issues arise, the 
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guidelines and its formulary status will be 
addressed at that time. 
Thanks to all for criteria input and 
compliance! 
FYI: DID YOU KNOW? 
Organidin liquid and tablets used to 
contain iodinated glycerol as its active 
ingredient. Wallace Labs has since 
changed the formulation to guaifenesin 
(same as Robitussina). The pharmacy 
department will dispense guaifenesin liquid 
and tablets, whenever OrganidinR is 
ordered. The iodinated glycerol 
formulation will no longer be 
manufactured. 
For outpatients, it wll be more cost-
effective to obtain either the guaifenesin 
liquid or tablets over-the-counter, rather 
than writing a prescription for Organidin 






A Service of LEHWVAILEY 
HOSPITAL 
Ionized Magnesium: A New Assay 
Magnesium is the fourth most abundant cation in the 
human body and the second most plentiful cation 
after potassium in body cells. The vast array of 
magnesium functions all derive from two biochemical 
reactions namely chelation with anionic ligands and 
competition with calcium for binding sites on 
membranes and proteins. Magnesium acts as a 
cofactor to activate more than 325 enzyme systems 
including 4 in the regulation of intermediate 
metabolism, 7 glycolytic, 4 tricarboxylic acid cycle 
and 12 photosynthetic enzymes. Within the nucleus 
magnesium binds to DNA to stabilize chromatic 
structure. By regulating RNA synthase and M-RNA 
attachment to ribosomes, ionized magnesium (MgH) 
ions are in control of cell growth, replication, and 
membrane structure. At the cell membrane, MgH 
regulates permeability, electrolyte flux and binding of 
hormones. 
However, magnesiums most important function is to 
act as an essential cofactor in the ATP dependent, 
ion shutUing Na/K pump which maintains sodium and 
potassium gradients across cell membranes. In 
addition the magnesium activation of ATP creates 
and maintains a 10,000 fold intra to intercellular 
calcium gradient Simply stated, magnesium is a 
calcium antagonist where .a decrease in magnesium 
would promote calcium movement into the cell 
prolonging contraction with resulting hypertension, 
cardiovascular, neuromuscular, psychiatric metabolic 
abnormalities, while an increased magnesium would 
have the exact opposite effect 
The distribution of magnesium in serum is similar to 
) that of calcium. Approximately one third of 
magnesium is found in protein, about 5% is 
complexed with ions such as citrate and/or 
phosphate and the remainder approximately 60% is 
in the free (ionized) state (Mg'). 
Due to advances in ion selective electrode 
technology ionized magnesium (MgH) is now 
available from Health Network Laboratories. At this 
time it is part of our emergency whole blood profile 
which is mos~y utilized by OR, ED and Trauma and 
as an individually orderable test on heparinized whole 
blood. Because MgH is a relatively new test, there 
are not many papers correlating increased or 
decreased values to specific disease states. By 
ordering the test we would expect that the physician 
would become as comfortable with interpreting MgH 
as total magnesium and relating values to health or a 
disease state. 
The clinical justification for a MgH is that the literature 
suggests that not only does total magnesium not 
correlate with intracellular magnesium but that 
intracellular magnesium measurements are more 
reflective of the severity of a magnesium deficiency 
than total serum magnesium. In contrast intercellular 
MgH appears to be comparable in concentration to 
excellular MgH. In addition the rapid transport of MgH 
between the intracellular and extracellular reservoirs 
is consistent with a dynamic equilibrium. To 
summarize, the extracellular MgH measurement 
reflects the dynamic intracellular-intercellular 
hemostasis and would be most likely to predict a 
physiologic response. 
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Some diseases, clinical settings or syndromes resulting in abnormal magnesiums are listed below. 
Hvoomaanesemia 



















Finally it is important to note that the recommended 
daily requirement for magnesium is 350 mg/day. 
Today a typical daily intake indicates a dietary 
shortfall of 90-180 mg/day in this country. It is 
interesting to note that strict vegetarians exhibit 
significanHy decreased incidencies of ischemic heart 
disease, sudden cardiac death, and hypertension and 




Mg containing drugs 
Mg treatment for eclampsia 
Acidemia 
Ad.disons hypothyroidism 
Please address any questions or concerns regarding 
this issue to John J. Shane, MD, Chairperson, 
Department of Pathology, at 402-8152, or Gerald E. 
Clement PhD, Technical Director, Clinical 




Health Sciences Library 
Computer Learning Resources 
April, 1996 
Saving your search in OVID 
Do you have a search that you do on 
a regular basis? Have you ever.spent hours 
doing a complex search only to be caUed 
away on an emergency? Well, don't loose 
the information you've just obtained, save it. 
To save your search strategy, you 
need to be at the main screen, the one which 
displays your search strategy. From this 
screen, type <CTRL>B, for save, and select 
Save Strategy. Here, you will be prompted 
for a name, a comment, and if this should be 
a temporary or permanent save. Temporary 
saves are automatically deleted every 24 
hours, permanent saves are not. 
All saved strategies are stored in the 
same location. If the name you have chosen 
is already in use, a message will be displayed. 
Simply choose Cancel and save your 
strategy using a different name. A comment 
will help differentiate your strategy from 
others with a similar name. 
To retrieve your strategy, again from 
the main screen, type <CTRL>F, for .file, 
choose Open from the file menu, and choose 
Open Strategy. A list of all saved strategies 
will be displayed. Simply use your arrow 
keys to locate your strategy and press 
<ENTER>. 
Micromedex Update. .. 
A problem has been discovered when 
printi~g from some areas ofMicromedex. 
After printing, the screen fills with 
unreadable characters. Even though the item 
you selected will print out normally, how 
you continue is not very obvious. 
If this does happen to you, to refresh 
the screen, you will need to type <ESC> X. 
This command will take you back to the 
previous menu and will refresh your screen. 
Micromedex has been made aware of 
the problem and is working on a solution 
that should evident in the near future. 
OVID Update. .. 
When to use which OVID icon: 
The only difference between the 
icons is where they print. 
OVID: This icon will print from all 
hospital workstations, if not, contact the I/S 
help desk at 8303. 
OVID_ Term: This icon is for use 
only on systems with a locally attached 
printer, i.e. your office computer. However, 
both your computer and your L VH _Net 
login must be specifically configured. If in 
doubt, use the OVID icon. 
* As we mentioned last month, the 
Ovid full text Biomedical Collection has 
arrived and should be available after March 
20, 1996. 
Suggestions and ideals are 
always welcome. If you would like to see 
a particular topic addressed, please 
contact Sherry Giardiniere, ext. 8406, or 
Christopher Sarley, ext. 1641. Both are 
available via E-mail. 
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HEALTH SCIENCES LIBRARY 
COMPUTER LEARNING RESOURCES 
TRAINING WORKSHOPS 
Apri/1996 
All workshops are hands-on. Call the 
Library at 402-8410 to register. 
All applications are available via the 
hospital network and you are required to 
have the icons available to you when you 
sign onto the network. 
INTRODUCTION TO OVID, 
MICROMEDEX, OPAC, INTERNET. •• 
Monday, Apri/15, 10:00AMto 12:00 Noon 
Monday, Apri/29, 10:00 AM to 12:00 Noon 
Location: Information Services Classroom, 
4th Floor, Cancer Center 
This workshop will cover the basic functions 
of each of the applications and how their 
usage can best be integrated into our daily 
job functions. Included will be an overview 
of the OVID databases, Micromedex Drug 
Interactions, how to use the automated card 
catalog (OP AC), and an introduction to the 
biomedical information available on internet. 
MEDLINE (OVID) 
Tuesday, April 2, 1:30- 3:30PM 
Wednesday, Apri/3, 9:30-11:30AM 
Tuesday, Apri/9, 1:30-3:30 PM 
Wednesday, Apri/10,.9:30-11:30AM 
Tuesday, Apri/23, 1:30-3:30 PM 
Wednesday, Apri/24, 9:30-11:30 AM 
(inform~l 2-3 people) 
Location: Cedar Crest Library 
Basic overview of the OVID interface will be 
covered. When to use the OVID and 
OVID Tenn icon, basic searching skills 
includ~g Subject, Textword, Limiting, 
combining, view. Printing and Saving, 
Retrieving a Saved Search. 
Internet- a little more WWW 
Keep in mind that internet addresses change 




This site provides hundreds of links 
to Biomedical Internet Resources. 
Information includes textbooks, case studies, 
patient information, and more 
Association of American Medical Colleges 
http:! lwww.aamc.org 
The Association of American 
Medical Colleges has a new Web Site 
available with information regarding many 
different subjects relating to healthcare, 
teaching hospitals, medical education and 
current medical news and events. It could be 
extremely helpful to those of us involved in 
Medical Education at L VH. 
Medconnect 
http:/ lwww.medconnect.com 
Provides a variety of programs for 
the physician including board review 
programs, case reviews, and medical news. 
(even includes an internet tutorial) 
Health Touch 
http:! lwww.healthtouch.com 
This particular site is intended for the 
consumer providing information on many 
health topics and diseases. It also contains a 
medication guide on drug uses, precautions, 




A supplement to medical records briefing December 1995 
Documentation transition to managed care 
As health care becomes a managed care environ-
ment, we physicians need to realize managed 
care's basic documentation tenets differ from 
those of fee-for-service medicine. That means we 
need to change the way we document patient 
care in the medical record. 
In a true managed care environment based on 
capitation, not all members are patients. The 
covered lives, to use a managed care term, actually 
consist of three sets-the well, the early sick, and 
the very sick. In this environment, cost manage-
ment is the major driving economic force. (No matter 
the reimbursement method, excellent care of the 
patient is still the prime directive of our profession.) 
Managed care includes sick and well 
In the managed care environment, the medical 
record must document appropriate care and 
evaluation of all patients as weB as good 
treatment of the early and very sick. 
The task, therefore, is monitoring healthy people 
who are in need of sqeening, education, vaccina-
tion, routine preventive care, and early diagnos-
tic testing, along with providing good documen-
tation of treatment and follow-up for illness and 
injury. Thus, practice guidelines will become a 
key component of the medical record, rather 
than only an intermittent component. 
What to include in the record 
The medical record under managed care will 
have at least the following two components: 
1. For all patients-practice guidelines for 
wellness status and illness prevention, including: 
• age/sex health screening, testing, and treatment; 
• predisposed conditions, evaluations, and 
management; 
• covered/noncovered services and proven and 
unproven treatments; and 
• outcomes measurement and patient satisfaction. 
2. For the early and very sick, include: 
• medical necessity, 
• medical appropriateness, 
• informed consent and alternative treatment 
options, and 
• outcomes measurement and patient satisfaction. 
Today's records fail 
Although it is conceivable that such a system could 
be developed in a paper en\'ironment, the system 
features described above are best developed as a 
major component of a standardized, computer-
ized health information management system. 
There are practical implications for physicians 
who are still documenting their patient interac-
tions in their own handwriting. 
For generalists or primary care providers using 
paper records, the record should document: 
• general health and preventive measures in one 
section of the record; and 
• individual problems, diagnoses, and treat-
ments-similar to problem lists-in another 
section of the record. 
MRB, P.O. Box 1168, Marblehead, MA 01945. Telephone 617/639-1872. Fax 617/639-2982. 
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For specialists using paper or electronic records, 
the record should include only the details of care 
outlined above for the early and very sick. 
The following items were contributed by 
MRB's sister publication Briefings on Prac-
tice Management. 
Medicare HMO enrollees get POS option 
The Health Care Financing Administration 
(HCF A) will permit health maintenance 
organizations (HMOs) to offer "point-:of-
service" (POS) benefits to Medicare recipi-
ents. A POS benefit allows HMO members to 
seek care outside the provider network. The 
patient pays a higher amount for the out-of-
network physician's services. 
According to the HCFA guidelines, Medicare 
managed care plans with risk-based con-
tracts may offer a POS benefit. Medicare pays 
risk plans a fixed amount for each enrollee, 
and these plans assume all the financial 
obligations of providing services to Medicare 
beneficiaries through their provider networks. 
Medicare will not make any additional 
payments to plans that offer a POS benefit. 
Questions about CLIA? Ask COLA 
The Commission on Office Laboratory Accredi-
tation (COLA) now has a free fax service to 
answer questions about the Clinical Laboratory 
Improvement Amendments of 1988 (CLIA). 
To request information, call800/298-8044. 
COLA has 33 fact sheets available on topics 
such as state lab licensure laws, writing a 
procedure manua~, registering a shared lab 
with the Health Care Financing Administra-
tion (HCFA), CLIA inspection, and how to 
respond after a CLIA survey. The COLA also 
offers phone support for issues the fact 
sheets don't cover. 
Dean R. Backstrom, MD, is the author of A Minute 
for the Medical Staff. He is a physician consultant 
for Healthcare Miznagement Advisors in Alpharetta, GA. 
HCFA's secondary-payer rule is final 
The Health Care Financing Administration 
(l-IeF A) has issued a secondary-payer rule 
that forbids group health plans from offering 
Medicare recipients different benefits than 
they offer to other plan members. It also 
prohibits employers from offering Medicare-
eligible employees incentives not to join the 
company's health insurance plan. 
HCFA doesn't want Medicare to become the 
primary payer in cases in which it should be 
the secondary payer of benefits. It will also 
demand refunds on claims that Medicare 
shouldn't have paid. 
The rule was effective October 2, but HCF A 
will enforce it retroactively to January 1987 
for coverage of disabled people; to December 
1989, for coverage of the elderly and benefi-
ciaries with end-stage renal disease; and 
August 1993, for failure of group plans to 
refund mistaken Medicare payments. 
HCFA may allow review requests by phone 
Soon you may be able to receive faster reviews 
on Part B initial claim determinations under 
a rule proposed by the Health Care Financing 
Administration (HCFA). The rule would allow 
beneficiaries and providers to request re-
views by telephone or electronic transmission. 
Telephone review requests would not be 
allowed, however, for determinations made 
by peer review organizations (PROs) or 
health maintenance organizations (HMOs). 
For more information, contact Rosalind Little 
of HCFA at 410/786-6972. 
A Minute for the Medical Staff is an exclusive service for subscribers to Medical Records Briefing. 










FAIR HEARING ANP APPELLATE REVIEW PROCESS 
SECTION !. • GENERAL TERMS. 
A. TITLE AND DEFINITIONS 
1. SHORT TITLE. 
The Fair Hearing and Appellate Review Process shall be referred to herein as the Fair Hearing Plan or Plan. 
2. DEFINITIONS. 
a. Aopellate Revjew Body means the group designated under this Plan to hear a request for appellate review 
properly filed and pursued by a Practitioner. 
b. ~means the Board of Trustees of the Hospital. Provided, however, that in instances in which the "Board" 
is charged with a certain function, duty or responsibility hereunder, nothing contained in this Plan shall preclude 
the Board from delegating any such function, duty or responsibility to any committee of the Board. 
c. Chjef Execytjye Offjcer !CEO! means the President of the Hospital or his or her designee. 
d. Hearjng Commjttee means the committee appointed under this Plan to hear a request for an evidentiary hearing 
properly filed and pursued by a Practitioner. 
e. Joint Conference Commjttee means the Joint Conference Committee of the Board as that committee is defined 
in the Hospital's Bylaws. 
f. Medjcal Execytjye Committee !MEC! means the Medical Executive Committee of the Medical Staff. 
g. Medjcal Staff means the Medical Staff of the Hospital. 
h. fA.I:lin means the Practitioner who requested the hearing or appellate review and the body or bodies whose 
adverse recommendation or action prompted the right to a hearing or appellate review under this Plan. 
i. Practitioner means the applicant or staff member against whom an adverse action has been recommended or 
taken. 
j. Appeals Commjttee means the Appeals Committee of the Board as determined and appointed by the Chairpersor 
of the Board of Trustees. 
k. Special Notjce means written notification sent by certjfjed or regjstered mail, return receipt requested. 
B. INTERPRETATION 
1. HEADINGS. 
The Headings in this Plan are intended only for reference purposes and shall not be construed as defining, limiting 
or describing the scope or intent of the Plan. 
2. NUMBERS. 
As used in the Plan and required by context, each number (singular or plural) shall include all numbers. 
3. GENDER. 
Whenever a personal pronoun is used, it shall mean a person of either gender. 
SECTION II. • HEARING PROCESS. 
A. INITIATION OF HEARING. 
1 . TRIGGERING EYENTS. 
a. Recommendations or Actjons. 
Except as otherwise set forth in the Bylaws, the following recommendations or actions, if deemed adverse under 
Section II. A.1.b. below, entitle the Practitioner to a hearing upon timely and proper request: 
( 1 l Denial of initial staff appointment; provided, however, that denial of initial appointment to the staff based upon 
the requirements of the current Medical Staff Development Plan shall not entitle the Practitioner to a hearing; 
{2) Denial of reappointment; 





(4) Revocation of staff membership; 
(5) Denial of requested appointment to or advancement in staff category; 
(6) Reduction in staff category; 
(7) Suspension or limitation of the right to admit patients or of any other membership prerogative directly related 
to the Practitioner's provision of patient care; 
(8) Denial of requested department (or service) or other clinical unit affiliation; 
(9) Denial or restriction of requested clinical privileges; 
(10) Reduction in clinical privileges; 
{11) Suspension of clinical privileges; 
{12) Revocation of clinical privileges; 
{13) Individual application of, or individual changes in, mandatory consultation requirement. 
b. When Deemed Adyerse. 
A recommendation or action listed in Section II.A.1.a. is adverse only when it has been: 
( 1) Recommended by the MEC; or 
(2) Taken by the Board under circumstances where no prior right to request a hearing existed. 
2. NOTICE OF ADYERSE RECOMMENDATION OR ACTION. 
The CEO shall promptly provide the Practitioner with special notice of an adverse recommendation or action. The 
notice to the Practitioner shall provide: 
( 1) that an adverse recommendation or action has been proposed to be taken against the Practitioner; 
{2) a summary of the reasons for the proposed recommendation or action; 
{3) that the Practitioner has the right to request a hearing on the proposed recommendation or action; 
(4) that the Practitioner has thirty (30) days after receiving the notice within which to submit a request for a hearing 
and that the request must satisfy the conditions set forth in Section II.B.; and 
(5) a summary of the Practitioner's rights and duties pursuant to Section II.C. 
A copy of the Medical Staff Bylaws and Fair Hearing and Appellate Review Process shall be included in the notice. 
B. REQUEST FOR HEARING. 
1. REQUEST FOR HEARING. 
A Practitioner has thirty (30) days after receiving notice under Section II.A.2. to file a written request for a hearing. 
The request must be delivered to the CEO either in person or by certified or registered mail. If the Practitioner intends 
to be represented by an attorney at the hearing, the request for a hearing must state that intent and the name of the 
Practitioner's attorney. 
2. FAILURE TO REQUEST HEARING. 
A Practitioner who fails to request a hearing within the time and in the manner specified in Section II.B. 1. waives his 
or her right to any hearing or appellate review to which he or she might otherwise have been entitled. 
C. PARTIES' RIGHTS AND DUTIES. 
1. RIGHTS Of·PARTIES. During a hearing, each party may: 
a. Call, examine, and cross-examint;~ witnesses; 
b. Present evidence determined to be relevant by the Presiding Officer {as hereinafter defined), subject to Section 
II.H.4. hereof; 
c. Request that the record of the hearing be made by the use of a court reporter; 
d. Request that copies of the said proceeding be available upon payment of any reasonable charges associated 
with the preparation thereof; and 
e. Submit a written statement at the closing of the hearing. 
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2. ADQITIONAL RIGHTS ANP DUTIES OF PRACTITIONER. 
a. Subject to Section II.B.1., the Practitioner may be accompanied and represented at the hearing by an individual 
of his or her choice, including an attorney. The body whose recommendation or action prompted the right to 
a hearing (as well as other interested committees or components of the Hospital, Board or Medical Staff) may 
be represented by an attorney at the hearing if and only if the Practitioner is represented by an attorney. The 
foregoing provision shall not be deemed to deprive the Practitioner or the body whose recommendation or actior 
prompted the right to a hearing of the right to legal counsel in connection with the preparation for the hearing. 
b. Upon completion of the hearing, the Practitioner has the right to receive the written recommendation of the 
Hearing Committee (as hereinafter defined). 
c. At least fifteen (15) days prior to a hearing, the Practitioner shall provide the body whose recommendation or 
action prompted the right to a hearing with a list of witnesses. The parties shall also exchange exhibits at that 
time and provide copies of the same to the Hearing Committee. 
3. FAILURE TO APPEAR. 
If the Practitioner fails, without good cause, to appear at the hearing, the right to a hearing and appellate review shall 
be forfeited. 
D. NOTICE OF HEARING. 
1. NOTICE. 
The CEO shall immediately deliver timely and proper hearing requests to the President of the Medical Staff or the 
Chairperson of the Board depending upon whose recommendation or action prompted the right to a hearing. Upon 
receipt of a request for a hearing, the President of the Staff or Chairperson of the Board, as appropriate, shall 
schedule and arrange for a hearing which shall be not later than sixty (60) days from the receipt of the request for 
the hearing. At least thirty (30) days prior to the hearing date, the CEO shall send the Practitioner special notice of 
the time, place and date of the hearing and of the composition of the hearing panel; provided, however, that a hearing 
for a Practitioner who is under suspension then in effect must be held as soon as the arrangements may be 
reasonably made, but not later than forty-five (45) days after the CEO received the hearing request. The notice of 
the hearing shall include a list of the witnesses (if any) expected to testify at the hearing on behalf of the body whose 
recommendation or action prompted the right to a hearing. 
E. HEARING PROCEDURE. 
1. APPOINTMENT OF HEARING COMMITTEE. 
a. By the Medjcal Staff. 
A hearing occasioned by an adverse MEC recommendation is conducted by a Hearing Committee appointed by 
the President of the Medical Staff composed of at least three (3) members of the Medical Staff Permanent 
Hearing Committee not in direct economic competition with the Practitioner involved. The President of the 
Medical Staff shall designate one (1) of the appointees as Chairperson of the Hearing Committee. 
b. By the Board. 
A hearing occasioned by an adverse action of the Board is conducted by a Hearing Committee appointed by the 
Chairperson of the Board and composed of five (5) persons, including at least two (2) members of the Medical 
Staff Permanent Hearing Committee, not in direct economic competition with the Practitioner. The Chairperson 
of the Board shall designate one ( 11 of the appointees as Chairperson of the Hearing Committee. 
c. Servjce on Hearjna Commjttee. 
(1) A Medical Staff or Board member is not disqualified from serving on a Hearing Committee merely 
because he or she participated in investigating the underlying matter at issue or because he or she has 
hea~d of the case or has knowledge of the facts involved or what he or she supposed the facts to be. 
A Medical Staff or Board member is disqualified from serving on a Hearing Committee if that Medical 
Staff or Board member is in direct economic competition with the Practitioner. 
(2) If the Practitioner has any objection to the composition of the hearing panel, the same must be raised in 
writing and delivered to either the President of the Medical Staff or the Chairperson of the Board, as 
appropriate, at least ten ( 1 0) days prior to the scheduled date of the hearing. The Practitioner's objection 
must state in sufficient detail the reasons and basis for the objection so made. The President of the Medical 
Staff or the Chairperson of the Board, as appropriate, in his or her sole discretion, will take action upon the 
objection. Action upon the objection may consist of the following: overruling the objection and proceeding 
with the hearing on the scheduled date; sustaining the objection, replacing one or more of the Hearing 
Committee members and proceeding with the hearing on the scheduled date; or sustaining the objection, 
replacing one or more of the Hearing Committee members, and rescheduling the hearing for a date not later 





2. HEARING OFFICER/PRESIDING OFFICER. 
a. Use of Hearjng Officer. 
The use of a Hearing Officer to assist the Hearing Committee at the hearing is optional and is to be determined by 
the President of the Medical Staff or the Chairperson of the Board, as appropriate. A Hearing Officer may or may 
not be an attorney at law, but must be experienced in conducting hearings. A Hearing Officer shall not be in direct 
economic competition with the Practitioner involved. 
b. Presidjng Officer. 
The Chairperson of the Hearing Committee or, in the Chairperson's discretion, the Hearing Officer, if any, shall be 
the Presiding Officer. The Presiding Officer maintains decorum and assures that all participants have a reasonable 
opportunity to present relevant oral and documentary evidence. The Presiding Officer shall determine the order 
of procedure during the hearing and shall make all rulings on procedure and the admissibility of evidence. The 
Presiding Officer may conduct pre-hearing conferences with the parties and is specifically empowered to impose 
reasonable limitations, including time limitations, upo~ the parties and the presentation of their cases. 
3. PERSONAL PRESENCE. 
a. Failure to Aopear. 
The personal presence of the Practitioner is required. A Practitioner who fails, without good cause, to appear and 
proceed at the hearing waives his or her rights in the same manner as provided in Section 11.8.3. 
b. Testjmony. 
If the Practitioner does not testify in his or her own behalf, he or she may be called and examined as if undet cross-
examination. 
4. PROCEDURE AND EYIDENCE. 
The hearing need not be conducted strictly in accordance with the rules of law relating to the examination of witnesses 
or presentation of evidence. During a hearing, each party may present evidence determined to be relevant by the 
Presiding Officer, regardless of its admissibility in a court of law. Furthermore, any relevant matter upon which 
reasonable persons customarily rely in the conduct of serious affairs may be considered, regardless of the admissibility 
of such evidence in a court of law. Each party is entitled, prior to or during the hearing, to submit memoranda 
concerning any issue of law or fact, and such memoranda shall become part of the hearing record. The Presiding 
Officer may, but is not required to, order that oral evidence be taken only on oath or affirmation administered by any 
person designated by him or her and entitled to notarize documents in the state where the hearing is held or, if the 
witness is unavailable, by affidavit. · 
5. OFFICIAL NOTICE. 
In reaching a decision, the Hearing Committee may take official notice, either before or after submission of the matter 
for decision, of any generally accepted technical or scientific matter relating to the issues under consideration and of 
any facts that may be judicially noted by the courts of the state where the hearing is held. Parties present at the 
hearing must be informed of the matters to be noticed, and those matters must be noted in the hearing record. Any 
party shall be given opportunity, on timely request, to request that a matter be officially noticed and to refute any 
officially noticed matter by evidence or by written or oral presentation of authority, in a manner to be determined by 
the Hearing Committee. The Hearing Committee is also entitled to consider all other information that can be considered 
under the Medical Staff Bylaws in connection with credentials matters. 
6. BURDEN OF PROOF. 
The body whose adverse action or recommendation prompted the right to a hearing has the burden of proof by clear 
and convincing evidence, in support thereof. 
7. HEARING BECOBQ. 
A court reporter shall be utilized to prepare a record of the hearing. 
8. POSTPONEMENT. 
Request for postponement of a hearing may be granted by the Hearing Committee only upon a showing of good cause 
and only if the request is made as soon as reasonably practicable. 
9. PRESENCE OF HEARING COMMITTEE MEMBERS. 
A majority of the Hearing Committee, but not less than three (3) members, must be present for each hearing and during 
deliberations on the decision. 
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1 0. RECESSES ANO APJOURNMENT. 
The Hearing Committee may recess and reconvene the hearing without additional notice for the convenience 
of the participants or for any other purpose. Upon conclusion of the presentation of oral and written 
evidence, the hearing shall be closed. The Hearing Committee, shall at a time convenient to itself, conduct 
its deliberations outside the presence of the parties. Upon conclusion of its deliberations, the hearing shall 
be adjourned. 
11. HEARING COMMITTEE REPORT. 
Within ten ( 1 0) days after final adjournment of the hearing, the Hearing Committee shall make a written report 
of its findings and recommendations and forwards the report along with the record and other documentation 
to the body whose adverse action prompted the right to a hearing to the Practitioner involved and to the CEO. 
The Hearing Committee Report shall include a statement of the basis for the recommendations or action. 
12. RECONSIPERATION. 
Upon written request of either party, the Hearing Committee shall have the right, in its sole and absolute 
discretion, to re-open a hearing prior to the issuance of a Hearing Committee Report or to reconsider the 
decision set forth in the Hearing Committee Report, if new and additional information is available. The 
Hearing Committee shall not re-open a hearing or reconsider a decision based upon new and additional 
information unless the party seeking to introduce the information can demonstrate that the information was 
not available or discoverable in time for presentation to the Hearing Committee at the original hearing.· 
F. EFFECT OF HEARING COMMITTEE REPORT. 
1. ACTION ON HEARING COMMITTEE REPORT. 
Within thirty-five (35) days after receiving the Hearing Committee Report, the body whose adverse 
recommendation or action occasioned the hearing considers it, and affirms, modifies or reverses its 
recommendation or action. It transmits the result to the CEO. 
2. NOTICE AND EFFECT OF RESULT 
a.~. 
The CEO shall promptly send a copy of the result of the body affirming, modifying, or reversing the 
recommendation or action taken by the Hearing Committee to the Practitioner by special notice, to the 
President of the Staff, to the MEC and to the Board. 
b. Effect of Favorable Result. 
( 1) By the Board. 
If the Board's result under Section II.F.1. is favorable to the Practitioner, it becomes the final 
decision of the Board. · 
(2) By the MEC. 
If the MEC result is favorable to the Practitioner, the CEO shall promptly forward it, together with 
all supporting documentation, to the Board and the Board shall take action consistent with Section 
II.F.3. of this Plan. 
c. Effect on Adverse Result. 
If the result of the MEC or the Board under Section II.F.1. continues to be adverse to the Practitioner, this 
special notice shall inform him or her of his or her right to request an appellate review as provided in 
Section Ill. of this Plan. 
3. BOARP ACTION AfTER FAVORABLE MEC RESULT. 
a.~. 
The Board shall, within thirty (30) days of receipt of a matter, render a decision. 
b. Effect of Favorable Actjon. 
If the Board's decision after a favorable MEC result is also favorable to the Practitioner, it becomes the 
final decision of the Board. 
c. Effect of Adyerse Actjon. 
If the Board's decision after a favorable MEC result is adverse to the Practitioner, the decision of the 
Board shall not be considered final. The CEO shall submit the matter to the Joint Conference Committee 
for further review and consideration. The Joint Conference Committee shall, within thirty (30) days after 





The CEO shall provide the Practitioner and the President of the Staff with notice of the recommendation 
of the Joint Conference Committee and/or the action and/or final decision of the Board. 
SECTION Ill.· APPELLATE REVIEW PROCESS. 
A. REQUEST FOR APPELLATE REVIEW. 
1. REQUEST FOR APPELLATE REVIEW. 
A Practitioner has thirty (30) days after receiving special notice under Section II.F.2.c. to file a written request 
for an appellate review. The request must be delivered to the CEO in person or by certified or registered mail 
and may include a request for a copy of the Hearing Committee Report and record and all other material, if 
not previously forwarded, that was considered by the Hearing Committee. If the Practitioner wishes to be 
represented by an attorney at any appellate review proceeding, the request for appellate review must state 
that desire and the name of the Practitioner's attorney. .. 
2. FAILURE TO REQUEST APPELLATE REVIEW. 
A Practitioner who fails to request an appellate review within the time and in the manner specified in Section 
III.A.1. waives any right to an appellate review to which he or she might otherwise have been entitled. 
B. NOTICE OF TIME AND PLACE FOR APPELLATE REVIEW. 
1. NOTICE. 
The CEO shall immediately deliver timely and proper requests for appellate review to the Chairperson of the 
Board. Upon receipt of a request for appellate review, the Chairperson shall schedule and arrange for an 
appellate review which shall not be later than sixty (60) days from the receipt of the request for appellate 
review. At least thirty (30) days prior to the appellate review, the CEO shall send the Practitioner special 
notice of the time, place, and date of the review and of the composition of the appellate·review panel. 
C. APPELLATE REVIEW PROCEDURE. 
1. APPELLATE REVIEW BOQy. 
If a MEC recommendation occasions the appellate review, the Appeals Committee of the Board shall serve 
as the Appellate Review Body. If a Board action occasions the review, the Joint Conference Committee shall 
serve as the Appellate Review Body. The Chairperson of the Board shall designate one (1) of the appointees 
as Chairperson of the Appellate Review Body. 
2. NATURE OF PROCEEQINGS. 
The proceedings conducted by the Appellate Review Body are a review based upon the hearing record, the 
Hearing Committee Report, all subsequent results and actions, the written and/or oral statements, if any, 
provided below, and any other material that may be presented and accepted under the appellate review 
procedure. 
3. HEARING OFFICER/PRESIDING OFFICER. 
a. Use of Hearjng Officer. 
The use of a Hearing Officer to assist the Appellate Review Body at the appellate review is optional and 
is to be determined by the Chairperson of the Board. A Hearing Officer may or may not be an attorney 
at law·, but must be experienced in conducting hearings and similar matters. A Hearing Officer shall not 
be in direct economic competition with the Practitioner involved. 
b. Presjding Offjcer. 
The Chairperson of the Appellate Review Body or, in the Chairperson's discretion, the Hearing Officer, 
if any, shall be the Presiding Officer. 
4. REPRiSENTAT!ON AT APPELLATE REVIEW. 
If the Practitioner desires to be represented by an attorney at an appellate review appearance, his or her 
request for the review pursuant to Section III.A.1. must declare his or her desire to be so represented. The 
Appellate Review Body shall determine in its sole discretion whether to permit such representation. The body 
whose recommendation or action prompted the right to a appellate review (as well. as other interested 
committees or components of the Hospital, Board or Medical Staff) may be represented by an attorney at the 
appellate review if and only if the Practitioner is represented by an attorney. The foregoing provision shall 
not be deemed to deprive the Practitioner or the body whose recommendation or action prompted the right 




5. WRITTEN STATEMENTS 
The Practitioner may submit a written statement detailing the findings of fact, conclusions and procedural 
matters with which he or she disagrees and his or her reasons for such disagreement. This written statement 
may cover any matters raised at any step in the hearing and appellate review process. The statement shall 
be submitted to the Appellate Review Body and the body whose adverse action promoted the appellate review 
through the CEO at least fourteen ( 14) days prior to the scheduled date of the appellate review, except if the 
time limit is waived by the Appellate Review Body. A similar statement may be submitted to the Appellate 
Review Body through the CEO by the body whose adverse action prompted the appellate review at least 
seven (7) days prior to the scheduled date of the appellate review. 
6. ORAL STATEMENTS. 
The Appellate Review Body, in its sole discretion, may allow the parties or their representatives to personally 
appear and present oral statements. Any party or representative appearing shall be required to answer 
questions of any member of the Appellate Review Body. 
7. POWERS. 
The Appellate Review Body has all the powers granted to the Hearing Committee, and any additional powers 
that may be reasonably appropriate to or necessary for the discharge of its responsibilities. 
8. PRESENCE OF MEMBERS. 
A majority of the Appellate Review Body must be present for each appellate review session and during 
deliberations. 
9. RECESSES ANP ADJOURNMENTS. 
The Appellate Review Body may recess and reconvene the proceedings without additional notice for the 
convenience of the participants or for any other purpose. At the conclusion of the oral statements, if allowed, 
the appellate review shall be closed. The Appellate Review Body shall then, at a time convenient to itself, 
conduct its deliberations outside the presence of the parties. The appellate review shall be adjourned at the 
conclusion of those deliberations. 
1 0. CONSIDERATION OF NEW OR APPITIONAL MATTERS. 
Upon written request of either party, the Appellate Review Body shall have the right, in its sole and absolute 
discretion, to consider new and additional information. The Appellate Review Body shall not consider any 
such new and additional information unless the party seeking to introduce the information can demonstrate 
that the information was not available or discoverable in time for presentation to the Hearing Committee at 
the original hearing. 
D. APPELLATE REVIEW ACTION 
1. ACTION TAKEN. 
Within thirty (30) days of adjournment, the Appellate Review Body may affirm, modify or reverse the adverse 
result or action, or in its discretion, may refer the matter back to the Hearing Committee for further review 
and recommendation to be returned to it within twenty (20) days and in accordance with its instructions. 
Within ten (10) days after receipt of such recommendation from the Hearing Committee the Appellate Review 
Body shall take action. 
a. Jojnt Conference Commjttee. 
If the Joint Conference Committee acted as the Appellate Review Body, it shall. submit its 
recommendation to the Board. The Board shall then render a final decision. 
b. Aopeals Commjttee. 
If the Appeals Committee acted as the Appellate Review Body, it shall submit its recommendation to the 
Board. If the Board's action is consistent with the last recommendation of the MEC, the decision shall 
be considered .final. If the Board's action is inconsistent with the last recommendation of the MEC, the 
decision ·of the Board shall not be considered final and the CEO shall submit the matter to the Joint 
Conference Committee for further review and co~sideration. The Joint Conference Committee shall, 
within thirty (30) days of receipt of ~he matter, submit its recommendation to the Board. The Board shall 
then render a final decision. 
2. NOTICE OF ACTION TAKEN. 
The CEO shall provide the Practitioner, the President of the Medical Staff, the MEC, the Appellate Review 
Body and the Board with notice of the recommendation and/or action taken by the Appellate Review Body, 







SECTION IV.- MISCELLANEOUS. 
A. MISCELLANEOUS. 
1 I NUMBER OF HEARINGS AND REYIEWS. 
Notwithstanding any other provision of the Medical Staff Bylaws or of this Plan, no Practitioner is entitled as 
a right to request more than one ( 1) evidentiary hearing and appellate review with respect to the subject 
matter that is the basis of the adverse recommendation or action which prompted such right. 
2. COMPLIANCE WITH BYLAWS. 
The failure by the Hospital ,or any of its committees or components to meet the conditions described in this 
Plan shall not, in itself, constitute a violation of any state or federal law or a deprivation of the Practitioner's 
due process rights. 
3. EXHAUSTION OF BEMEPIES. .. 
If an adverse recommendation is made or action taken pursuant to Section !I.A. of this Plan, the Practitioner 
must first exhaust the remedies afforded by the Medical Staff Bylaws and this Plan before resorting to legal 
action. The fact that a Practitioner has exhausted the remedies afforded by the Medical Staff Bylaws and 
this Plan shall not in any way suggest that any subsequent legal action is proper or appropriate. 
4. GRAPHIC SUMMARY. 
A graphic summary of the Fair Hearing and Appellate Review Process is attached hereto as Exhibit A. The 
summary should be used for informational purposes only and should not be deemed to grant any additional 
rights or impose any additional duties on the parties. In the event of any discrepancy between the Plan and 
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